New York State Common Retirement Fund’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $600K | Hold |
52,688
| – | – | ﹤0.01% | 1851 |
|
|
2025
Q1 | $626K | Buy |
52,688
+31,493
| +149% | +$374K | ﹤0.01% | 1822 |
|
|
2024
Q4 | $399K | Hold |
21,195
| – | – | ﹤0.01% | 2018 |
|
|
2024
Q3 | $476K | Sell |
21,195
-4,177
| -16% | -$93.8K | ﹤0.01% | 1958 |
|
|
2024
Q2 | $530K | Buy |
25,372
+9,041
| +55% | +$189K | ﹤0.01% | 2024 |
|
|
2024
Q1 | $240K | Buy |
16,331
+175
| +1% | +$2.57K | ﹤0.01% | 2353 |
|
|
2023
Q4 | $167K | Buy |
16,156
+6,025
| +59% | +$62.3K | ﹤0.01% | 2538 |
|
|
2023
Q3 | $80K | Buy |
10,131
+200
| +2% | +$1.58K | ﹤0.01% | 2835 |
|
|
2023
Q2 | $99K | Sell |
9,931
-10,006
| -50% | -$99.7K | ﹤0.01% | 2840 |
|
|
2023
Q1 | $177K | Sell |
19,937
-11,100
| -36% | -$98.5K | ﹤0.01% | 2639 |
|
|
2022
Q4 | $341K | Buy |
31,037
+12
| +0% | +$132 | ﹤0.01% | 2500 |
|
|
2022
Q3 | $404K | Buy |
31,025
+149
| +0.5% | +$1.94K | ﹤0.01% | 2446 |
|
|
2022
Q2 | $391K | Buy |
30,876
+8,255
| +36% | +$105K | ﹤0.01% | 2472 |
|
|
2022
Q1 | $317K | Buy |
22,621
+33
| +0.1% | +$462 | ﹤0.01% | 2617 |
|
|
2021
Q4 | $654K | Sell |
22,588
-86
| -0.4% | -$2.49K | ﹤0.01% | 2301 |
|
|
2021
Q3 | $679K | Sell |
22,674
-4,360
| -16% | -$131K | ﹤0.01% | 2299 |
|
|
2021
Q2 | $717K | Buy |
27,034
+8,794
| +48% | +$233K | ﹤0.01% | 2391 |
|
|
2021
Q1 | $567K | Buy |
18,240
+7,800
| +75% | +$242K | ﹤0.01% | 2393 |
|
|
2020
Q4 | $343K | Buy |
10,440
+4,100
| +65% | +$135K | ﹤0.01% | 2526 |
|
|
2020
Q3 | $221K | Buy |
+6,340
| New | +$221K | ﹤0.01% | 2603 |
|